Immuneering Corp (IMRX)
1.81
-0.13
(-6.70%)
USD |
NASDAQ |
Nov 15, 16:00
1.81
0.00 (0.00%)
After-Hours: 20:00
Immuneering Gross Profit (Annual): 0.00 for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| December 31, 2022 | 0.1588M |
| December 31, 2021 | 0.9269M |
| Date | Value |
|---|---|
| December 31, 2020 | 1.031M |
| December 31, 2019 | 0.6967M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
2023
1.031M
Maximum
2020
0.5627M
Average
0.6967M
Median
2019
Gross Profit (Annual) Benchmarks
| Singular Genomics Systems Inc | -0.558M |
| Biomarin Pharmaceutical Inc | 1.904B |
| Integra Lifesciences Holdings Corp | 884.74M |
| Eton Pharmaceuticals Inc | 21.06M |
| Tenon Medical Inc | 1.241M |